On ECHEMI
Home > Drugs > Acute mastitis
Acute mastitis
Acute mastitis is an acute suppurative infection of the breast. It is an inflammation of the connective tissue in and around the mammary ducts. It often forms an abscess in a short period of time. It is mostly caused by the invasion of Staphylococcus aureus or Streptococcus along the lymphatic vessels. It often occurs in women who are breastfeeding after childbirth, especially primiparas. The bacteria usually invade from the cracks or fissures of the nipples, or they can directly invade and cause infection. Literature reports that 50% of primiparas suffer from acute mastitis, and the ratio of primiparas to multiparas is 2.4:1. It can occur at any time during the lactation period, but it is most common 3 to 4 weeks after delivery, so it is also called puerperal mastitis.
  • Site of disease:

    breast
  • Infectious :

    Not contagious
  • Frequent population:

    Primipara
  • Related symptoms:

    Lactation disorder milk stasis milk duct obstruction reduced milk secretion swollen lymph nodes
  • Concurrent disease:

Related Drugs
Niuhuang Xingxiao Pills
Manufacturer:

Jiuzhaigou Valley Scenic and Historic Interest Area Natural Medicine Co., Ltd.

Dandelion granules
Manufacturer:

Shenyang DONGXIN Pharmaceutical Co., Ltd.

Dandelion granules
Manufacturer:

Jiangxi Xincheng Pharmaceutical Co., Ltd.

Rupixiao Tablets
Manufacturer:

Shenyang Hongyao Group Co., Ltd.

Small gold capsule
Manufacturer:

Jianmin Pharmaceutical Group Co., Ltd.

Tamoxifen Citrate Tablets
Indication: 1. To treat recurrent and metastatic breast cancer in women. 2. To be used as an adjuvant therapy for metastatic breast cancer after surgery to prevent recurrence.
Yanlixiao Capsules
Manufacturer:

Diaoyutai Medicine Group Ji Lin Tian Qiang Drugs Manufacture Limited Liability Company

Yanlixiao Capsules
Manufacturer:

Tonghua Baixin Pharmaceutical Co., Ltd.

Yanlixiao Capsules
Manufacturer:

Hunan Jiudian Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.